First Quarter 2017 Results for US Dialysis Providers

Restricted access

For the first quarter of 2017, the dialysis business for Fresenius Medical Care North America (FMCNA) grew by 14% (10% at constant currency). Quarterly growth was influenced by the positive effect of an agreement with the US Departments of Veterans Affairs (VA) and Justice for a settlement for underpayment, a favorable impact from commercial payers, and an increased number of treatments. Dialysis care revenue for the quarter rose to $2.65 billion from $2.32 billion from the first quarter of 2017 to the first quarter of 2016.

DaVita had overall patient service revenues of $2.6 billion in the first quarter of